Pynomax-OD
Tranexamic Acid 500mg Sustained Release Tablets
1. Works on all pathogenic mechanisms in melasma
2. Diminishment in 82.4% patients within one month of treatment
3. Diminishment in 94.6% patients within two month of treatment
4. Overall significant improvement seen in 94.6% of patients